The N-Terminal Half of NPM Dissociates from Nucleoli of HeLa Cells after Anticancer Drug Treatments
- 14 October 1999
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 264 (1), 305-309
- https://doi.org/10.1006/bbrc.1999.1255
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- A study of correlation between NPM-translocation and apoptosis in cells induced by daunomycinBiochemical Pharmacology, 1999
- Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5).Proceedings of the National Academy of Sciences, 1996
- Quantitation of the nucleophosmin/B23-translocation using imaging analysisCancer Letters, 1996
- Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's LymphomaScience, 1994
- Characterization and cellular localization of nucleophosmin/B23 in HeLa cells treated with selected cytotoxic agents (studies of B23-translocation mechanism)Experimental Cell Research, 1992
- Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growthBiochemistry, 1989
- Effects of actinomycin D analogs on nucleolar phosphoprotein B23 (37,000 daltons/pI 5.1)Biochemical Pharmacology, 1985